Atıf Formatları
Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. ÖZCAN Et Al. , "Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF," CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3, pp.437-449, 2021

ÖZCAN, S. Et Al. 2021. Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF. CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3 , 437-449.

ÖZCAN, S., LEVENT, S., & CAN, N. Ö., (2021). Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF. CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3, 437-449.

ÖZCAN, SANİYE, SERKAN LEVENT, And NAFİZ ÖNCÜ CAN. "Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF," CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3, 437-449, 2021

ÖZCAN, SANİYE Et Al. "Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF." CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3, pp.437-449, 2021

ÖZCAN, S. LEVENT, S. And CAN, N. Ö. (2021) . "Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF." CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.3, pp.437-449.

@article{article, author={SANİYE ÖZCAN Et Al. }, title={Challenges, Progress and Promises of Impurities Annotation for LCMS-IT-TOF}, journal={CURRENT PHARMACEUTICAL ANALYSIS}, year=2021, pages={437-449} }